Vaxcyte, Inc. PCVX
60.65 USD -1.38 -2.22%
As of Nov 2, 1:47 PM ET
39.87 52-week range 90.75
- YTD
- +31.45%
- 1 year
- +33.95%
- Open
- 61.88
- Prev close
- 62.03
- Mkt cap
- 9.54B
- Vol
- 517.07K
- Avg vol
- 2.08M
- EPS
- -7.62
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 60.15
- High
- 62.87
- Forward P/E
- -8.71
- Beta
- 1.23
- Short ratio
- 4.40
- Inst. own
- 111.05%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 61.59
- 200-d avg
- 56.97
- 1y target
- 117.30
5Y chart
Chart tools
Chart is warming up
The five-year price history for PCVX has not been loaded yet. Try again in a moment.
Altman Z-Score
13.53 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
P/E -8.2×
P/S 0.0×
P/B 2.3×
P/FCF -9.4×
EV/EBITDA -8.5×
EV/Sales 0.0×
FCF Yield -10.7%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -28.5%
ROIC -32.5%
ROA -25.2%
Revenue 0.0%
Operating Income -62.2%
EPS (diluted) -48.2%
Free Cash Flow -40.9%
Current Ratio 7.9×
Quick Ratio 7.9×
Debt / Equity 0.1×
Net Debt / EBITDA -0.1×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31
